Ginkgo Bioworks (NYSE:DNA)
- Net Outflows of from Institutional Investors in Dollars
- $2,305,413,721.00
- Net Outflows of from Institutional Investors in Shares
- 294,057,873
- Number of Institutional Transactions in the Last 90 Days
- 21
Ginkgo Bioworks Holdings, Inc, together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.
Read More
